SCHEMBL6153469

SCHEMBL6153469

O=C(O)c1ccc(CC2CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.80
CCR3 P51677 1/20 0.74
MEN1 O00255 4/20 0.73
KMT2A Q03164 4/20 0.73
ALDH1A1 P00352 2/20 0.69
LTA4H P09960 1/20 0.67
SMN1; SMN2 Q16637 2/20 0.65
LMNA P02545 2/20 0.64
KDM4E B2RXH2 1/20 0.60
GLA P06280 1/20 0.60
MAPT P10636 1/20 0.60
HTT P42858 1/20 0.60
ATM Q13315 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
KDM1A O60341 2/20 0.60
DRD2 P14416 1/20 0.60
MAOB P27338 1/20 0.60
HTR2A P28223 1/20 0.60
SLC6A4 P31645 1/20 0.60
SCN5A Q14524 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153849 0.89 GAA (1.00) GAACCR3MEN1KMT2AALDH1A1
SCHEMBL27533416 0.87 CCR3 (0.68) GAACCR3MEN1KMT2AALDH1A1
SCHEMBL2004615 0.86 CCR3 (1.00) GAACCR3MEN1KMT2AALDH1A1
SCHEMBL27519383 0.85 HDAC4 (0.71) MEN1KMT2AALDH1A1LTA4HSMN1; SMN2
SCHEMBL7977320 0.85 CCR3 (0.96) GAACCR3MEN1KMT2AALDH1A1
SCHEMBL8191786 0.85 CCR3 (0.96) GAACCR3MEN1KMT2AALDH1A1
SCHEMBL6156526 0.84 GAA (0.70) GAACCR3MEN1KMT2AALDH1A1
SCHEMBL12813692 0.84 KDM1A (0.57) GAACCR3MEN1KMT2AKDM1A
SCHEMBL12642472 0.84 CCR3 (0.81) GAACCR3ALDH1A1KDM4EGLA
SCHEMBL12965517 0.84 GAA (0.60) GAACCR3MEN1KMT2ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 GAA 2875/4885CCR3 2563/4885MEN1 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.